换一批
换一批Characterising the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 cases.
作者：
Jonathan,Mitchell [1]
;
Niedzica,Camacho [1]
;
Patrick,Shea [2]
;
Konrad H,Stopsack [3]
;
Vijai,Joseph [4]
;
Oliver,Burren [1]
;
Ryan,Dhindsa [1]
;
Abhishek,Nag [1]
;
Jacob E,Berchuck [5]
;
Amanda,O'Neill [1]
;
Ali,Abbasi [1]
;
Anthony W,Zoghbi [6]
;
Jesus,Alegre-Díaz [7]
;
Pablo,Kuri-Morales [8]
;
Jaime,Berumen [7]
;
Roberto,Tapia-Conyer [7]
;
Jonathan,Emberson [9]
;
Jason M,Torres [9]
;
Rory,Collins [9]
;
Quanli,Wang [10]
;
David,Goldstein [2]
;
Athena,Matakidou [1]
;
Carolina,Haefliger [1]
;
Lauren,Anderson-Dring [1]
;
Ruth,March [1]
;
Vaidehi,Jobanputra [2]
;
Brian,Dougherty [11]
;
Keren,Carss [1]
;
Slavé,Petrovski [1]
;
Philip W,Kantoff [12]
;
Kenneth,Offit [4]
;
Lorelei A,Mucci [13]
;
Mark,Pomerantz [5]
;
Margarete A,Fabre [14]
作者单位：
Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
[1]
Institute for Genomic Medicine, Columbia University, New York, New York, USA.
[2]
Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.;Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA.
[3]
Cancer Biology and Genetics Program, Sloan Kettering Institute, New York, New York, USA.;Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.;Department of Medicine, Weill Cornell Medical College, New York, New York, USA.
[4]
Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
[5]
Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.
[6]
Faculty of Medicine, National Autonomous University of Mexico, Copilco Universidad, Coyoacán, Ciudad de México, Mexico.
[7]
Faculty of Medicine, National Autonomous University of Mexico, Copilco Universidad, Coyoacán, Ciudad de México, Mexico.;Instituto Tecnológico y de Estudios Superiores de Monterrey, Tecnológico, Monterrey, Nuevo León, Mexico.
[8]
Clinical Trial Service Unit & Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
[9]
Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Waltham, Massachusetts, USA.
[10]
Oncology R&D, AstraZeneca, Waltham, Massachusetts, USA.
[11]
Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.;Convergent Therapeutics, Cambridge, Massachusetts, USA.
[12]
Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA.;American Cancer Society, Boston, Massachusetts, USA.
[13]
Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.;Department of Haematology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.;Department of Haematology, University of Cambridge, Cambridge, UK.
[14]
DOI
10.1101/2024.05.10.24307164
PMID
38766261
发布时间
2025-02-05
- 浏览0
medRxiv
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
